Abstract: A combination preparation comprising a compound which has a phosphodiesterase-inhibiting action, and a compound which reduces the biologically effective intracellular Ca2+ content, is suitable for the treatment of immunological diseases.
Type:
Grant
Filed:
July 20, 1999
Date of Patent:
January 8, 2002
Assignee:
Hoechst Aktiengesellschaft
Inventors:
Martin Schönharting, Stefan Müllner, Peter Zabel